[Federal Register Volume 70, Number 73 (Monday, April 18, 2005)]
[Page 20187]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-7655]



Advisory Committee on the Medical Uses of Isotopes: Meeting 

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Updated notice of meeting.


SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
April 20 and 21, 2005. Although the dates of the ACMUI public meeting 
remain April 20 and 21, as originally published in the February 28, 
2005 notice (see 70 FR 9611), this notice is meant to alert interested 
parties that the time for the ACMUI's briefing to the Commission has 
changed. See heading below entitled ``Date and Time for Commission 
Briefing'' for details. A sample of agenda items to be discussed during 
the public sessions includes: (1) Status of Rulemaking: Pt. 35 Training 
and Experience; (2) Status and Update: Redefining Medical Events; (3) 
Case Experience in Using I-125 Seeds as Markers; (4) FDA Radiation Dose 
Limits for Human Research Subjects Using Certain Radiolabeled Drugs, 
and (5) Establishing Guidance on Exceeding Dose Limits for Members of 
the Public who would serve as Caregivers to Persons undergoing 
Radiopharmaceutical Therapy. To review the agenda, see http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda/ or contact 
[email protected].
    Purpose: Discuss issues related to 10 CFR 35, Medical Use of 
Byproduct Material.
    Date and Time for Closed Session Meeting: April 21, 2005, from 8 
a.m. to 10 a.m. This session will be closed so that NRC staff can brief 
the ACMUI on sensitive information regarding protective security 
measures, and so that the ACMUI can discuss internal personnel matters.
    Dates and Times for Public Meetings: April 20, 2005, from 8 a.m. to 
5 p.m.; and April 21, 2005, from 10 a.m. to 5 p.m.
    Address for Public Meetings: Bethesda North Marriott Hotel, 5701 
Marinelli Road, North Bethesda, MD 20552-2785.
    Date and Time for Commission Briefing: April 20, 2005, from 3:15 to 
4:45 p.m.

FOR FURTHER INFORMATION CONTACT: Angela R. McIntosh, telephone (301) 
415-5030; e-mail [email protected] of the Office of Nuclear Material Safety 
and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Angela R. McIntosh, U.S. Nuclear Regulatory 
Commission, Two White Flint North, Mail Stop T8F5, 11545 Rockville 
Pike, Rockville, MD 20852-2738. Submittals must be postmarked by April 
1, 2005, and must pertain to the topics on the agenda for the meeting.
    2. Questions from members of the public will be permitted during 
the meeting, at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection on NRC's Web site (www.nrc.gov) and at the NRC Public 
Document Room, 11555 Rockville Pike, Rockville, MD 20852-2738, 
telephone (800) 397-4209, on or about July 20, 2005. This meeting will 
be held in accordance with the Atomic Energy Act of 1954, as amended 
(primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. 
App); and the Commission's regulations in Title 10, U.S. Code of 
Federal Regulations, Part 7.
    4. Attendees are requested to notify Angela R. McIntosh at (301) 
415-5030 of their planned attendance if special services, such as for 
the hearing impaired, are necessary.

    Dated at Rockville, Maryland, this 12th day of April, 2005.

    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 05-7655 Filed 4-17-05; 8:45 am]